Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

Clinical trial NCT01574235 · COMPLETED

Trial details

NCT number: NCT01574235
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Solid Tumors Malignant Hemopathy Chemotherapy-induced Febrile Neutropenia (FN)

Start date: 2011-10-01
Primary completion: 2014-02-01
Enrollment: 2114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.